Literature DB >> 26778651

Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors.

Natalia Maldonado1, Bibiana Castro2, Indira Berrio3, Miguel Manjarrés4, Carlos Robledo5, Jaime Robledo6.   

Abstract

INTRODUCTION: Carbapenems resistance is a growing phenomenon and a threat to public health because of the reduced therapeutic options for resistant infections.
METHODS: A retrospective case-control study was conducted in 2 tertiary-care hospitals in Medellín, Colombia. Fifty patients infected with ertapenem-resistant enterobacteriaceae were compared with a control group consisting of 100 patients with infections caused by ertapenem susceptible enterobacteriaceae. A multivariate logistic regression model was used to identify factors that best explain ertapenem-resistant enterobacteriaceae infections.
RESULTS: The factors associated with ertapenem-resistant enterobacteriaceae infections were prior exposure to carbapenems (adjusted OR 3.43; 95% IC 1.08-10.87) and prior exposure to cefepime (adjusted OR 6.46; 95% IC 1.08-38.38).
CONCLUSION: Prior exposure to antibiotics is the factor that best explains the ertapenem-resistant enterobacteriaceae infection in this population, highlighting the importance of antimicrobial stewardship programs in hospitals.
Copyright © 2015 Elsevier España, S.L.U. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Carbapenem resistance; Carbapenems; Carbapenémicos; Enterobacteriaceae infections; Factores de riesgo; Infecciones por Enterobacteriaceae; Resistencia a carbapenémicos; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 26778651     DOI: 10.1016/j.eimc.2015.11.009

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  4 in total

1.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Daily inpatient ertapenem therapy can be an alternative to hospitalization for the treatment of complicated urinary tract infections during the COVID-19 pandemic.

Authors:  Arzu Nazli Zeka; Vildan Avkan-Oguz; Caglar Irmak; Oya Eren Kutsoylu; Sema Alp Cavus; Ziya Kuruüzüm; M Cem Ergon
Journal:  Int J Clin Pract       Date:  2021-04-20       Impact factor: 3.149

Review 3.  [Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis].

Authors:  M Collard; Z Lakkis; J Loriau; D Mege; C Sabbagh; J H Lefevre; L Maggiori
Journal:  J Chir Visc       Date:  2020-04-30

Review 4.  Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis.

Authors:  M Collard; Z Lakkis; J Loriau; D Mege; C Sabbagh; J H Lefevre; L Maggiori
Journal:  J Visc Surg       Date:  2020-04-24       Impact factor: 2.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.